Rain Wen, Phd

Rain Wen, Phd Email and Phone Number

Founder and CEO of Milkomeda Capital, Venture Capitalist in Biotech and AI @ Milkomeda Capital
Rain Wen, Phd's Location
San Francisco Bay Area, United States, United States
About Rain Wen, Phd

I am a versatile professional with a diverse background encompassing science, entrepreneurship, venture capital, and philanthropy.My journey began with a PhD focused on CRISPR gene editing, which laid the foundation for my entrepreneurial endeavors. During my postdoctoral studies at Stanford, I co-founded a pioneering biotech startup alongside two esteemed professors. I was honored to be selected as a SPARK Scholar at Stanford University.Transitioning into the venture capital space, I founded Milkomeda Capital, where I concentrate on early to late-stage investments in biotechnology and artificial intelligence (AI).In addition to my investment activities, I am passionate about advancing AI applications in healthcare, environmental sustainability, and energy solutions. I was honored to be selected as a reviewer for the Bezos Earth Fund's $100 million AI for Climate and Nature Grand Challenge. I actively support groundbreaking innovations aimed at improving our planet.

Rain Wen, Phd's Current Company Details
Milkomeda Capital

Milkomeda Capital

View
Founder and CEO of Milkomeda Capital, Venture Capitalist in Biotech and AI
Rain Wen, Phd Work Experience Details
  • Milkomeda Capital
    Founding And Managing Partner (Milkomeda Ai Fund)
    Milkomeda Capital Aug 2023 - Present
  • Milkomeda Capital
    Chairwoman Of The Board
    Milkomeda Capital May 2022 - Present
  • Milkomeda Capital
    Founder And Ceo (Milkomeda Biotech Fund)
    Milkomeda Capital May 2022 - Present
    Milkomeda Capital is a venture capital investment firm with two distinct funds. One fund focuses on investments in biotechnology and medical technology, while the other fund is dedicated to artificial intelligence and AI-related opportunities.The name “Milkomeda” is inspired by the merging of two galaxies: the Milky Way and Andromeda, which will eventually collide to form a new galaxy known as Milkomeda. Our investment interests span a range of sectors, including therapeutics, medical devices, and the application of AI in biotechnology and healthcare. We typically invest between $1 million and $10 million per deal, enabling us to support innovative companies at various stages of development.
  • Stanford University
    Spark Scholar
    Stanford University Mar 2023 - Present
    Stanford, Ca, Us
    SPARK is an incubator at Stanford University that fosters translational science and research. SPARK provides access to specialized knowledge and technical expertise regarding drug and diagnostic development, dedicated core laboratory facilities, and sources of funding to support translational efforts.
  • Stanford University
    Deep Learning In Medicine Class Student
    Stanford University 2024 - 2024
    Stanford, Ca, Us
    This class covers neural network architecture, computer vision, natural language processing, convolution neural networks, classification, and regression. Students of this class gain an intuitive understanding of how foundational AI models work, how they are trained, and where they are revolutionizing medicine today.
  • Emmecell
    Board Observer
    Emmecell Feb 2023 - Present
    Menlo Park, California, Us
    Emmecell is a privately held, clinical-stage biotechnology company pioneering the discovery and development of first-in-class cell therapies for the treatment of eye diseases.
  • Biotechnology Innovation Organization
    Bio Investor Forum Session Moderator
    Biotechnology Innovation Organization Oct 2024 - Oct 2024
    Washington, Dc, Us
    BIO is the world’s largest advocacy association representing biotechnology companies, academic and research institutions across the United States and in more than 30 other nations. It’s my honor to serve as a BIO Investor Forum Seed Stage Spotlight Moderator.
  • Bezos Earth Fund
    Ai For Climate And Nature Grand Challenge Reviewer
    Bezos Earth Fund Aug 2024 - Sep 2024
    Washington, D.C., Us
    I was honored to be selected as a reviewer of the Bezos Earth Fund $100 million AI for Climate and Nature Grand Challenge. The Bezos Earth Fund is exploring new ideas for multiplying the impact of climate and nature efforts using modern AI. The first round of the Grand Challenge will focus on sustainable proteins, power grid optimization, and biodiversity conservation, in addition to embracing visionary wildcard solutions for climate and nature.
  • Epistimi.Org
    Epistimi Us-Japan Foundation Leadership Program Participant
    Epistimi.Org Aug 2024 - Sep 2024
    Cambridge, Ma, Us
    A leadership-competencies training program designed for early career Japanese and U.S. women in STEM offered by Epistimi, Inc., and funded by the US-Japan Foundation, pharmaceutical giant Takeda, and Japan’s biggest energy company Jera.
  • American Academy Of Ophthalmology
    Member-In-Training
    American Academy Of Ophthalmology 2021 - 2022
    San Francisco, Ca, Us
  • Stanford University Graduate School Of Business
    Stanford Gsb Ignite Program Participant
    Stanford University Graduate School Of Business 2020 - 2021
    Stanford, Ca, Us
    A certified business program at Stanford Graduate School of Business (GSB) about business innovation, entrepreneurship, accounting, financing, and marketing.
  • Association For Research In Vision And Ophthalmology (Arvo)
    Member-In-Training
    Association For Research In Vision And Ophthalmology (Arvo) 2013 - 2018
    Rockville, Maryland, Us

Rain Wen, Phd Skills

Molecular Biology Crisprcas9 Business Development Public Speaking Adeno Associated Virus Life Sciences Fundraising Gene Therapy Philanthropy Genomics

Rain Wen, Phd Education Details

  • Stanford University
    Stanford University
    Ophthalmology & Epigenetics
  • The University Of British Columbia
    The University Of British Columbia
    Cell And Develomental Biology

Frequently Asked Questions about Rain Wen, Phd

What company does Rain Wen, Phd work for?

Rain Wen, Phd works for Milkomeda Capital

What is Rain Wen, Phd's role at the current company?

Rain Wen, Phd's current role is Founder and CEO of Milkomeda Capital, Venture Capitalist in Biotech and AI.

What schools did Rain Wen, Phd attend?

Rain Wen, Phd attended Stanford University, The University Of British Columbia.

What skills is Rain Wen, Phd known for?

Rain Wen, Phd has skills like Molecular Biology, Crisprcas9, Business Development, Public Speaking, Adeno Associated Virus, Life Sciences, Fundraising, Gene Therapy, Philanthropy, Genomics.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.